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AbstrAct
Objectives  The aim of this study was to explore the 
views and experiences of a group of Spanish women 
suffering from chronic migraine (CM).
setting  Headache clinic at a university hospital in Madrid 
(Spain).
Participants  Purposeful sampling of patients that 
attended a specialised headache clinic for the first 
time between June 2016 and February 2017 was 
performed. The patients included were females aged 
18–65 and with positive diagnoses of CM according 
to the International Classification of Headache 
disorders (third edition, beta version), with or 
without medication overuse. Accordingly, 20 patients 
participated in the study with a mean age of 38.65 
years (SD 13.85).
Design  Qualitative phenomenological study.
Methods  Data were collected through in-depth 
interviews, researchers’ field notes and patients’ 
drawings. A thematic analysis was performed 
following appropriate guidelines for qualitative 
research.
results  Five main themes describing the significance 
of suffering emerged: (a) the shame of suffering from 
an invisible condition; (b) treatment: between need, 
scepticism and fear; (c) looking for physicians’ support 
and sincerity and fighting misconceptions; (d) limiting 
the impact on daily life through self-control; and (e) 
family and work: between understanding and disbelief. 
The disease is experienced as an invisible process, and 
the journey to diagnosis can be a long and tortuous 
one. Drug prescription by the physician is greeted 
with distrust and scepticism. Patients expect sincerity, 
support and the involvement of their doctors in relation 
to their disease. Pain becomes the main focus of 
the patient’s life, and it requires considerable self-
control. The disease has a strong impact in the work 
and family environment, where the patient may feel 
misunderstood.
conclusions Qualitative research offers insight into the 
way patients with CM experience their disease and it may 
be helpful in establishing a more fruitful relationship with 
these patients.
IntrODuctIOn
Migraine is one of the main causes of disability 
worldwide,1 with a global prevalence of 12%.2 
The International Classification of Head-
ache Disorders (third edition, beta version: 
ICHD-3 beta) defines chronic migraine 
(CM) as a headache registered on more than 
15 days a month, over more than 3 months, 
that on a minimum of 8 days each month 
has the typical characteristics of migraine, or 
responds to triptans or ergot drugs.3 CM is 
always a progression from episodic migraine 
(EM),4 and as the frequency of headaches 
increases, it is common for the clinical 
features of migraine to change and character-
istic migraine episodes combine with other 
less painful episodes that resemble tension-
type headaches. In some cases, patients with 
CM suffer headaches of such persistence 
that it becomes impossible to distinguish 
individual episodes of pain.5 CM is the most 
common cause of chronic daily headache, 
with a global prevalence between 0.5% and 
5%,6 and an estimated 2.5% of patients with 
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Research
strengths and limitations of this study
 ► This study presents new data on the perception 
of chronic migraine (CM) among female patients 
attending a specialised headache clinic for the first 
time.
 ► In-depth interviews and descriptions of patients’ 
drawings were used to collect qualitative data as 
they enable the patient’s experiences with chronic 
pain to be analysed.
 ► Although the results cannot be extrapolated to the 
entire population of patients with CM, they can 
help physicians better understand the impact of the 
disease and the patients’ perspectives.
 ► The findings of this study may help to improve the 
management of patients with CM.
group.bmj.com on November 16, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Palacios-Ceña D, et al. BMJ Open 2017;7:e017851. doi:10.1136/bmjopen-2017-017851
Open Access 
EM progress to CM each year.7 CM mainly affects females 
(with a 2.5–6.5 higher frequency than in males), and it is 
associated with other risk factors, such as age, time since 
migraine onset, overuse of analgesics or low socioeco-
nomic status.7–10 Frequently, comorbidity exists with other 
disorders such as chronic pain, anxiety, depression and 
obesity.8
Standardised questionnaires, such as the Headache 
Impact Test (HIT-6), the Migraine Disability Assessment 
Scale or the Short Form-36, have demonstrated that CM 
is more debilitating and causes a stronger reduction in 
quality of life than EM.11–13 Nevertheless, the true life 
experience and impact of the disease are extremely 
personal, and there are aspects that cannot be measured 
with scales or questionnaires. Individual perspectives and 
the account of pain are relevant, inasmuch as one’s life 
experiences, aspirations and emotional needs must be 
considered when treating the individual.14 Qualitative 
research (QR) can provide a more holistic picture that 
may be more meaningful to practitioners.15 16 Indeed, QR 
has already been used to analyse how migraine affects a 
patients’ work, leisure, social and family life.17–20 It has 
also been applied to the analysis of patients’ expecta-
tions of the healthcare system and different therapeutic 
resources, including alternative therapies, and control 
strategies adopted by the patients themselves.21–27 
However, no qualitative study to date has focused on CM, 
the most debilitating form of migraine. By using qualita-
tive methods, we aimed to answer the following research 
question: ‘what is the lived experience of patients with 
CM?’.28 Thus, the purpose of this study was to explore 
the experiences and perspectives of a group of Spanish 
women suffering from CM.
MethODs
Design
A qualitative phenomenological study was carried out to 
address the experiences of Spanish women with CM. In 
the field of qualitative studies, phenomenology attempts 
to understand other people’s lived experiences by using 
first-person narratives and other sources such as personal 
letters, diaries and drawings.29 30 Moreover, phenom-
enological studies aim to mitigate the effects of any 
preconceptions (bracketing).31 32 In our study, bracketing 
was achieved by carefully recording the positions taken 
by the researchers beforehand and by using in-depth 
interviews as the main data collection tool.28 32 In this 
way, we sought to avoid the researcher’s influence on the 
data and reveal the nature of the phenomenon through 
the patients’ accounts.29 Phenomenology has proved to 
be useful to explore the individual meaning of chronic 
pain.30
research team
Prior to the study, the position of the researchers was 
established according to their previous experience 
and their motivation.29 Nine researchers (six men and 
three women) participated in this study, three of whom 
(DPC, BNM, CFP) had experience in qualitative study 
designs and were not involved in clinical activity and had 
no prior relation with the participants. The remaining 
investigators (LSH, DMC, LLF, HGM, DGA, MLC) had 
clinical and research experience with neurological 
patients.
Participants and sampling strategies
Patients with CM (n=20) that attended the headache clinic 
at the neurology department of the Hospital Clínico San 
Carlos (Madrid) for the first time were enrolled on the 
study between June and December 2016. All patients were 
recruited at their first visit to the clinic to ensure that none 
of them had experienced a significant improvement—or 
even a reversal to EM—at the time of the study. The inter-
views were scheduled in the following 2 weeks. Purposeful 
sampling based on the relevance to the research question 
and not clinical representativeness was employed,33 and 
sampling continued until redundant information from 
the data analysis was achieved.29
The subjects included in the study were females aged 
18–65 years old and with a diagnosis of CM according to 
ICHD-3 beta,3 with or without medication overuse. The 
exclusion criteria included: (a) the occurrence of other 
headaches, primary or secondary, different to medication 
overuse headache; (b) other chronic pain syndromes; (c) 
serious systemic and/or psychiatric disorders; (d) inability 
to communicate in Spanish or to sign the informed 
written consent.
Data collection
Data were collected between June 2016 and February 
2017. Based on the phenomenological design, first-
person data collection tools (in-depth interviews and 
drawings) and researcher’s field notes were used simul-
taneously.29In-depth interviews (unstructured and 
semistructured) were used as the main tool for data collec-
tion. With participants 1–10, the interview started with 
an open question: ‘What is your experience with CM?’. 
Thereafter, the researchers listened carefully, noted the 
key words and topics identified in the patients’ responses 
and used their answers to ask for and clarify the content.29 
In this way, relevant information was collected from the 
perspective of the patients. Also, during the interviews, 
researchers used prompts or probes: (a) to encourage 
the patients to provide more detail (‘Can you tell me 
a bit more about that?’), (b) to encourage the partici-
pant to keep talking (‘Have you experienced the same 
thing since?’), (c) to resolve confusion (paraphrasing of 
something that the patient had said) and (d) to show full 
attention by the researcher (‘That’s really interesting, 
please tell me more’).29
A first analysis was performed on the unstructured inter-
views of participants 1–10. This analysis revealed some 
relevant topics that required further study, thus making 
it necessary to include a second stage of data collec-
tion. This second stage (participants 11–20) consisted of 
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Table 1 Semistructured interview questionnaire
Issue studies Questions
Disease How would you describe your pain? And your condition? What does it mean to you?
What elements, factors or situations affect your experience of pain?
How much do you know about your headache and the disease you suffer?
How do you feel during a migraine crisis? What does it mean to you?
How has your headache evolved over the past few years?
What do asymptomatic periods mean to you?
What aspects of the disease are most relevant to you?
Diagnoses What prompted you to seek medical help for the first time?
Could you explain the process of your diagnosis? What doctors and specialists did you visit, what 
tests were performed, etc?
Could you describe the most relevant aspects of the attention you received from your GP and from 
your neurologist?




What do you consider to be the most relevant aspect of the treatment that has been prescribed to 
you?
What do you think about the treatment?
Do you adhere to the treatment? Why?
Strategies
Are there any strategies you adopt to cope with your pain?
Have you received any advice to control your pain that differs from that of your doctor?
Have you taken any substance other than the treatment prescribed to control your pain? Why?
Have you tried any alternative medicines? Yoga, reiki, homeopathy. Why?
Doctor–patient 
relationship
How would you describe your relationship with your doctor? What is the most important thing for 
you?
How do you think this relationship influences your disease?
What do you think that the physicians think about migraine?
Have you had to visit A & E services and for what reason?
What did it mean to you to have to visit the A & E services?
What was the most relevant aspect of having to visit A & E?
Daily life What are the most relevant changes you have made in your life because of CM?
How much and in what ways does CM restrict you?
Working environment Has your job suffered because of your condition?
How do you think that your workmates and your boss perceive your disease?
Have you ever hidden your headache at work? Why?
Socio-family 
environment
What have been the most relevant changes in your social and family life? And with respect to your 
partner?
Has your relationship with your partner, friends and close relatives changed because of your 
condition? If so, in what way?
Do you usually hide your migraine from your partner, family or friends? Why?
How do you believe other people perceive migraine?
A&E, emergency department; CM, chronic migraine; GP, general practitioner.
semistructured interviews that were based on a question 
guide designed to gather information regarding specific 
topics of interest (table 1).29
All the interviews were tape-recorded and transcribed 
verbatim, recording 1951 min of interviews overall. The 
first 10 interviews ranged in length from 73 to 135 min 
(mean 102.9; SD 22.34), and the second set of interviews 
ranged from 70 to 139 min (mean 103.86; SD 37.61). 
The interviews were held at the patient’s home (n=10), 
a coffee shop (n=3) or in a private room at the hospital 
(n=7), depending on the patient’s preference. Interviews 
were carried out at a time when patients were not experi-
encing pain (n=5) or when they suffered only mild (n=3) 
or moderate (n=12) pain. None of the patients postponed 
their interview even when experiencing some degree of 
pain. No third party was present at the interviews apart 
from the participant being interviewed.
At the end of the interviews, the patients provided 
drawings that gave further insight into how they viewed 
their illness.18 34 35 Thus, when the interview reached the 
point where the participant had no more new informa-
tion to offer, they were asked to draw a picture of what it 
is like to live with CM. Participants were provided with a 
blank piece of paper and 24 coloured crayons for their 
drawing. The interview then continued with a description 
of the picture starting with the question: ‘What does the 
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picture represent?’ Then researchers asked the patients 
to describe the content of their drawings and the reasons 
for their choice of colour, spatial organisation and compo-
sition. Patients’ drawing descriptions and researcher field 
notes were part of the analysed data. Throughout data 
collection, these sources supported the previous ones and 
were often used for triangulation.29
Sociodemographic and clinical data were also recorded 
for each participant, as well as their Beck Depression 
Inventory (second edition: BDI-II)36 and State-Trait 
Anxiety Inventory (STAI)37 scores. In qualitative studies, 
the collection of sociodemographic and clinical data 
helps to understand patients’ experiences and narrations, 
helps to situate them in a concrete context and serves to 
achieve the transferability of the results.29
The full literal transcription of each of the interviews, 
the patients’ drawing descriptions and the researchers’ 
field notes were all collated to perform a qualitative 
analysis. Finally, data collection was pursued until the 
researcher achieved information redundancy, at which 
point no new information emerged from data analysis (in 
our study, this occurred with patient 20).29
Data analysis
A thematic analysis was performed, which began by 
analysing the most descriptive content in order to arrive 
at meaningful units, and then went into further depth to 
produce thematic code groups (ie, grouping meaningful 
units referring to the same issue or with the same content 
until the main topics emerged). To identify the relevant 
content, researchers read and reread the data at three 
different levels: literally, interpretively and reflexively.29 In 
this way, an increasing level of abstraction and complexity 
was established for the analysis from meaningful units to 
thematic code groups and finally themes.29 Each interview 
was analysed by two researchers, separately. After the anal-
ysis, meetings were held to show and compare the results 
obtained. These meetings were held with a frequency of 
2 weeks, either face-to-face or by videoconference.
For clarity, a matrix was built with the results obtained 
from the analysis. Subsequently, joint meetings were held 
to combine the results of the analysis. In the case of differ-
ences in opinion, theme identification was performed 
based on consensus among the research team members. 
After that, the research team held joint meetings to show, 
combine and integrate the results of the analysis from 
each matrix. At that point, all researchers analysed and 
discussed the matrixes results and identified final themes 
by consensus among all members.29 38 The final outcome 
was the identification of themes that represented the 
patients’ experiences of suffering CM. No qualitative 
software was used to analyse the data. The analysis was 
performed by the researchers who had contact with the 
patients (DPC, BNM, CFP).
rigour
The guidelines established by the Consolidated Criteria 
for Reporting Qualitative Research39 were followed. The 
data verification method consisted of: (a) cross-triangula-
tion by the researchers, which involved planning sessions 
where the cases analysed by each team member were 
presented in order to reach a consensus; (b) auditing 
of the material obtained from the participants by an 
external independent researcher; and (c) postinterview 
and postanalysis patient verification.40
ethical considerations
The study was approved by the Clinical Research Ethics 
Committee at the ‘Hospital Clínico San Carlos’ (code: 
16/054-E: see technical online supplementary appendix 
1). Informed consent and permission to record the inter-
views was obtained from each patient.
results
Twenty female patients with CM were enrolled on this 
study, and the mean age of the participants was 38.65 years 
(SD 13.85). Five patients had completed basic education, 
six secondary education and six higher education. At 
the time of the study, two patients were in the course of 
completing their university degrees and one patient was 
finishing her secondary education. All patients had an 
active lifestyle as two of them were housewives, while the 
remainder were either studying or working outside the 
home. At the time of the study, the mean time since the 
onset of migraine onset was of 20.2 years (SD 13.23), and 
the median of time since migraine had become chronic 
was 2 years (IQR 0.8–5 years). In the 3 months prior to 
the interviews, the patients had presented a mean of 24.6 
headache days per month (SD 4.7), with 12.85 days a 
month of moderate to intense pain (SD 6.03) and the use 
of symptomatic medication (paracetamol, non-steroidal 
anti-inflammatory drugs, triptans or opiates) on a mean 
of 14.1 days (SD 8.91) a month. All the patients except 
one had received one or more oral preventive medica-
tion, with no significant response or with an insufficient 
response. However, none of the patients had been treated 
with nerve blocks or botulinum toxin injections prior to 
recruitment. According to the BDI-II scores, five patients 
suffered mild depression and three moderate depression. 
Moreover, 14 patients showed some degree of anxiety as 
a state and 15 as a trait according to the STAI scores (see 
table 2 for the full demographic and clinical features of 
all the participants).
When the material obtained from the participants was 
analysed, five specific themes emerged: (a) the shame 
of suffering from an invisible condition; (b) treatment: 
between need, scepticism and fear; (c) looking for physi-
cians’ support and sincerity and fighting misconceptions; 
(d) limiting the impact on daily life through self-control; 
and (e) family and work: between understanding and 
disbelief. These five emerging themes were evident in the 
narratives taken directly from the patients’ interviews and 
patients’ drawings descriptions (see examples in table 3).
theme 1: the shame of suffering from an invisible condition
CM is experienced with frustration given that patients fail 
to achieve complete pain relief despite specialist referral 
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and the use of medication. All patients indicate a feeling 
of uncertainty when they observe how changes in their 
lifestyle and following standard recommendations fail 
to guarantee pain relief. Most of them describe CM as 
an invisible disease as their illness cannot be objectively 
demonstrated through diagnostic tests. Some patients 
admit feeling ashamed of seeking medical help for an 
invisible and little recognised disease. The arriving at a 
diagnosis is described as a long and tortuous process, 
reminiscent of an obstacle course. Many had to visit 
several doctors before being diagnosed with CM.
theme 2: treatment: between need, scepticism and fear
The use of pharmacological drugs is perceived with 
distrust and scepticism by most patients, since acute 
treatment (symptomatic) does not provide complete 
pain relief and preventive treatment does not completely 
avoid pain resurgence. Patients do not believe they will 
become pain free and, to them, a successful treatment 
should reduce pain to levels that would allow them to live 
a ‘normal’ life and to get on with their lives.
Paradoxically, and despite distrust of analgesic and 
other symptomatic treatments, some patients recognise 
that they need to have analgesic medication at hand wher-
ever they go and whatever they do. Having the medication 
handy reassures the patients, as they can take this medica-
tion if pain emerges. The majority of patients admitted to 
having at some stage taken analgesic medication that they 
had used before, often in a cocktail, or to self-medicating 
with unprescribed substances.
Long-term preventive treatments are not well accepted, 
and some patients do not adhere to them or they abandon 
them. Many patients read the patient information leaflet, 
and they become apprehensive about the potential 
short and long-term adverse effects, some of which they 
have even experienced in the past and reproach being 
prescribed the same kind of drugs anew. They are also 
sceptical when prescribed medication that includes anti-
depressants, antiepileptic or antihypertensive drugs, as 
they feel these are not relevant to their situation. Many 
patients are dubious about the effectiveness of preventive 
medication, and some of them abandon the treatments 
when they experience no reduction in pain as they are 
not willing to continue taking a large number of pills. 
Some patients also reported being afraid of becoming 
addicted to these treatments, as they must be taken daily, 
in addition to painkillers. Thus, many of them finally opt 
for controlling their pain with analgesics or other symp-
tomatic treatments.
theme 3: looking for physicians’ support and sincerity and 
fighting misconceptions
Patients do not expect a complete cure as they have 
assumed their pain is chronic. Some obstacles appear 
between patients and doctors. However, they do expect 
truthful information and sincerity from their doctors 
regarding the prospects of treatment, the progress of the 
disease and its significance. Most patients prefer to be 
presented with real alternatives, which offer them options 
(and hope) of controlling or lessening the pain, and to 
be provided with reliable information about their disease. 
They also appeal for support and involvement, describing 
how they feel isolated when having to deal with their pain 
and how they need to feel the support of their doctors, 
whereby their disease must involve both of them.
Conversely, all patients identify situations that hinder 
the physician–patient relationship, such as: when a doctor 
prescribes a treatment that has already been tried unsuc-
cessfully in the past, when inefficient treatments are 
maintained for a long time, when migraine is viewed as 
a minor symptom or affliction, when stereotypes about 
women (‘they are more nervous and stressed’) are used 
to explain the disease, when a family history of migraine 
is considered a limiting factor to perform exploratory 
tests and when referral to specialists is delayed.
theme 4: limiting the impact on daily life through self-control
Pain is a constant theme in the patients’ life, everything 
revolves around pain. The majority of patients convey 
resignation at not being able to live completely pain free 
and they have learnt to accept that they must live with it. 
Nonetheless, patients attempt to change their habits for 
fear that they may trigger pain. This change in lifestyle 
is the consequence of the fact that everything revolves 
around pain. Moreover, those changes have an impact 
on the patients and on their partners and family. Many 
patients also suffer mood swings and irritability, which 
affect their relationship with partners, family and friends. 
For this reason, they live in a constant state of self-control. 
They can’t allow pain to overwhelm them and rule their 
lives. Keeping up this demanding level of self-discipline 
on a daily basis can be challenging, particularly at times 
of higher emotional stress. Only one participant (patient 
15) spoke of the impact of migraine during pregnancy, a 
patient who experienced anxiety in anticipation of pain 
as the use of painkillers was restricted.
theme 5: family and work: between understanding and 
disbelief
Patients encounter a lack of understanding at work, 
where workmates and managers are reluctant to believe 
that a headache could have such a strong effect. Many of 
them try to hide the symptoms and diagnoses for fear of 
being discredited and losing their jobs. Paradoxically, the 
majority of patients describe how they force themselves to 
continue to work or to return early from sick leave despite 
the pain, in order to avoid overburden their colleagues.
Most patients grant that they find more understanding 
in their family circles than at work. However, there is a 
certain degree of disbelief even among family members 
that their pain could be so debilitating or that they are 
not exaggerating their pain. Some patients are worried 
that they might have contributed to their children suffering 
migraine in the future by having submitted them to stress, 
being unable to attend family events (celebrations, school 
meetings, etc), because their children might imitate their 
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behaviour (staying in a dark room) or because they might 
have passed it on in their genes.
DIscussIOn
Our results show how pain becomes the central focus in 
the life of patients with CM and it demands a high level 
of self-control. The illness is experienced as an invisible 
process, and the route to a diagnosis can be long and 
arduous. Medication does not produce complete pain 
relief, and prescriptions are perceived with scepticism. It 
is expected that doctors will be sincere, supportive and 
become involved in the patient’s disease. This condition 
has a strong impact on the patient’s work and family 
circles, where they often feel misunderstood.
To the best of our knowledge, this is the first study to 
describe the experiences of patients with CM using a qual-
itative analysis. QR has previously been applied to analyse 
the impact of migraine or of ‘chronic daily headache’—
in general—on patient’s lives22–27; however, this is the 
first study to focus specifically on CM as defined by the 
ICHD-3 beta diagnostic criteria. The patient’s accounts, 
together with sociodemographic and clinical data, were 
collated to provide an in-depth insight of the patients’ 
situation. Different data collecting tools were used in 
order to extract more information.29 Yet this study still has 
some limitations concerning generalisability that limit the 
extrapolation of our results to the whole population with 
CM. Chiefly, the study was limited to women, and as such, 
it does not reflect the impact of CM in men, although a 
population in which it is much less common. Second, the 
study was performed on patients attending a specialised 
headache clinic for the first time; therefore, our findings 
do not extend to patients with CM who have not visited 
a headache clinic or specialist, and likewise, we have not 
analysed the experiences of patients treated or managed 
in a specialised headache clinic for some time. This limita-
tion could have influenced our results since purposeful 
sampling could have included women who were partic-
ularly dissatisfied with prior medical care. Another issue 
that might have influenced the results was the fact that 
three of the interviews were conducted in coffee shops; 
although the participants chose the coffee shop as a 
reliable and comfortable place, the environment in this 
setting could have limited confidentiality.38
Our results are consistent with previous studies that 
reveal that migraineurs, for the most part women, expe-
rience helplessness and a lack of control over their own 
life.17 18 22 41–43 Acceptance of the disease as well as the 
uncertainty of success to calming the pain and preventing 
migraine attacks (by a change of lifestyle and by following 
medical recommendations and treatment) can be a way 
to regain control over the disease.17 22
Migraine has already been referred to as an invisible 
affliction.18 43 In addition, patients with migraine are 
thought to construct a representation of their illness 
based on five dimensions: beliefs about the disease aeti-
ology, the diagnostic label and associated symptoms, 
the impact of the disease, the disease duration and the 
existence of a cure and control.43 Flaws in any of these 
dimensions can lead to wrong assumptions,44 including 
disregarding migraine as a real disease39 or its consid-
eration as a minor disease,24 25 consequently generating 
shame in patients for seeking help.41 Invisibility could 
account for visits to different practitioners,41 as well as 
underdiagnosis or delayed diagnosis.45 46
Our results show that while patients are wary of the 
treatments prescribed to them, they take the medication 
to control the impact of CM on their lives. Patients with 
migraine and chronic daily headache have previously 
been said to distrust treatments,18 22 based on the failure 
to achieve complete pain control or to prevent further 
episodes.15 18 41 It has also been shown how patients take 
medication in order to feel safer and to feel that they are 
regaining control of their life.17 18 22 44 The patients’ low 
expectations and fear of side effects justify why headache 
sufferers find using acute medications more acceptable 
than using prophylactic drugs on a daily basis.25 Radat et 
al43 showed that migraine is perceived as successive crises 
but not as a progressive disease, which can explain why 
some patients resent long-term treatments that must be 
taken continuously without immediate effect.
Doctor–patient relationships are of paramount impor-
tance in order to actively engage the patient in taking 
control of the disease and adhering to treatments.25 Our 
patients expect their doctor to become involved in their 
disease, consistent with previous studies that also found 
that the relationship between doctors and patients must 
be based on sincerity, honesty, communication and under-
standing of the patient’s experience, prioritising this 
over achieving symptom remission.47 48 Previous studies 
reported that patients with chronic daily headache are 
more satisfied with doctor consultations when manage-
ment is shaped to their needs and when they feel that they 
are listened to and their concerns are understood.22 25 43 
Rutberg and Öhrling,18 and Varkey et al22 showed that 
patients commonly feel that they are not taken seriously, 
a sense of not being believed or that the physicians lack 
knowledge about migraine prevention. Previous studies 
also document a prevailing general belief that migraine 
is a ‘women’s disorder’, which exacerbates gender bias in 
seeking help and diagnosis.49 50
As occurred in our patients, pain has previously been 
described as the centre of everything, having an impact on 
all dimensions of the patient’s life, their family and social 
relationships.22 24 41 43 Patients’ perceptions of the impact 
of their disease vary depending on the patients’ commit-
ments (work and family), their belief in their ability to 
cope and their ability to fit their lives around their head-
aches.22 24 Our results also agree with previous studies 
that described an attitude of resignation and withdrawal 
from activities,22 41 43 44 as well as mood swings, irritability 
and aggression that hinder personal relationships and 
work.18 43 Pain management may require a high degree 
of self-control, vigilance and constant involvement, all of 
which can affect the patient’s quality of life.17 18 41 51 As 
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previous studies show,17 18 41 patients with migraine have a 
choice between strict compliance with recommendations 
(increasing the probability of avoiding pain, although 
involving more stress and life restrictions) and a more 
permissive approach, accepting that it won’t be possible 
to control all the factors that potentially trigger pain (with 
less life restrictions but a higher risk of pain).
Special consideration must be given to migraine during 
pregnancy; while pain improves for the majority of preg-
nant women, a small number experience a worsening of 
migraine particularly during the first and third trimes-
ters.52 53 Whenever pain does not cease during pregnancy, 
the medication and/or alternative therapeutic options 
available to women are limited52; this was the case in one 
of our patients.
Our results coincide with those of other authors 
describing how patients experience certain disbelief 
when talking about their pain in social circles and often 
hide their disease and its symptoms.17 18 24 44 Patients with 
chronic headache and migraine hide their disease for 
fear of losing their job, due to a lack of understanding by 
workmates/family, and given the notion that migraine is 
unacceptable in society.18 22 24 44 Headache is not accepted 
in its full magnitude in the patient’s social circles, and 
as such, it is regarded as an excuse to interrupt social 
and work obligations.17 18 44 With regards the workplace, 
migraine has a considerable impact on a patients’ ability 
and working efficiency during pain episodes, leading to 
changes in the workplace, and in the specific job tasks 
they can perform.18 44 Paradoxically, to avoid being 
brought into doubt, many women push themselves to 
continue working despite suffering a migraine attack.18
In agreement with previous studies,27 44 our patients 
were worried about the potential emotional impact 
their disease might have on their children, as they may 
on occasion be unfit to attend family events, they suffer 
mood swings, among others. Moreover, it has previously 
been shown how women that suffer migraines are inse-
cure about their ability to take care of their own children, 
their condition influencing the patient’s self-esteem as 
mothers and spouses.44
In conclusion, this study provides insight on how CM 
is experienced in a group of Spanish women attending a 
specialised headache clinic. Our results are in line with 
previous data based on patients with migraine or chronic 
daily headache. Moreover, our findings shed light on 
how CM may impact the lives of patients in a similar situ-
ation and may have important implications for clinical 
practice. Patients need the involvement and support of 
their doctors and the patient–doctor relationship must be 
viewed as an important element in the strategy to improve 
the management of CM. Knowing the patients’ experi-
ences can probably contribute to a better communication 
between clinicians and patients and to a greater compli-
ance with treatments. Our study also provides grounds 
to guide further research into quality of life of patients 
with CM. In particular, it will be interesting to analyse 
the experience of patients who have undergone specific 
treatments for CM, such as botulinum toxin injections, 
and those who have been treated at specialised headache 
clinics for some time.
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